MedTrace Logo

Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty

NCT07657962 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-08-25

No results posted yet for this study

Summary

The goal of this observational study is to learn whether using an autologous free dermal graft during breast reduction surgery helps maintain lower breast pole shape over time in women undergoing primary bilateral reduction mammaplasty.

The main question it aims to answer is:

Does autologous free dermal graft support reduce lower pole lengthening between 1 month and 6 months after surgery?

Researchers will compare two groups of participants. One group will undergo superior pedicle vertical scar reduction mammaplasty with autologous free dermal graft support as part of routine surgical care. The other group will undergo the same basic breast reduction technique without autologous free dermal graft support.

Participants will:

* Have their planned breast reduction surgery as part of routine care
* Attend postoperative follow-up visits at 1, 3, and 6 months
* Have standard breast measurements and medical photographs taken during follow-up
* Complete a breast satisfaction questionnaire at 6 months

Conditions

  • Breast Ptosis
  • Mammaplasty
  • Lower Pole Elongation
  • Postoperative Breast Pseudoptosis

Interventions

PROCEDURE

Autologous Free Dermal Graft Support

Placement of a de-epithelialized autologous free dermal graft in the lower pole region during superior pedicle vertical scar reduction mammaplasty. The dermal graft is obtained from the participant's own de-epithelialized skin during the planned breast reduction procedure and is used as an autologous structural support method. The graft is not vascularized and does not remain attached to a dermal or glandular pedicle. No synthetic or biological mesh material is used.

Sponsors & Collaborators

  • Cumhuriyet University Hospital

    lead OTHER

Principal Investigators

  • Handan Derebaşınlıoğlu · Cumhuriyet University

  • Murat Çelik, Assistant Professor · Cumhuriyet University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-24
Primary Completion
2028-02-28
Completion
2028-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07657962 on ClinicalTrials.gov